Aurora Cannabis Inc. (ACB)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
12.04+0.08 (+0.67%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 11.96 |
| Open | 12.85 |
| Bid | 11.81 x 2200 |
| Ask | 11.89 x 1400 |
| Day's Range | 11.85 - 13.32 |
| 52 Week Range | 3.71 - 26.40 |
| Volume | 45,620,941 |
| Avg. Volume | 42,836,375 |
| Market Cap | 2.221B |
| Beta (5Y Monthly) | 3.26 |
| PE Ratio (TTM) | 55.74 |
| EPS (TTM) | 0.22 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Aurora Cannabis Inc. (ACB) Gains As Market Dips: What You Should Know
In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $12.04, marking a +0.67% move from the previous day.
- Investor's Business Daily
Marijuana Stocks Jump On Democratic Senate; Are Any Good Buys Now?
Marijuana stocks surged as a Democratic Senate adds to cannabis legalization momentum. Are any pot stocks good buys now amid profitability challenges?
- Investor's Business Daily
Aphria Stock, Marijuana Stocks Rally On Sales Beat, But Analyst Cites These Concerns
Aphria stock and other marijuana stocks jumped on Thursday, after the Canadian cannabis producer reported fiscal second-quarter revenue that beat expectations. The pot grower reported the results after it agreed to merge with rival Tilray — potentially creating a global weed-industry giant — and as more focus shifts to the U.S. and its legalization prospects. Aphria reported net sales of 160.5 million Canadian dollars, or around $126.57 million.
© 2021 Verizon Media. All rights reserved.
